100 Recruiting Studies Using Oxaliplatin
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Oxaliplatin
NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer
📍 OHSU Knight Cancer Institute — Portland, Oregon
Pancreatic Adenocarcinoma
View Study & Checklist ➔A Study Evaluating Efficacy and Safety of Mosunetuzumab in Combination With Polatuzumab Vedotin Compared to Rituximab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
📍 City of Hope Cancer Center — Duarte, California
Non-Hodgkin Lymphoma
View Study & Checklist ➔Phase I/II Study of Perioperative Chemotherapy Plus Immunotherapy Followed by Surgery in Localized Esophageal and Gastroesophageal Adenocarcinoma
📍 M D Anderson Cancer Center — Houston, Texas
Clinical Stage II Esophageal Adenocarcinoma AJCC v8
View Study & Checklist ➔Trial Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative Management
📍 University of California, Irvine — Irvine, California
Rectal Cancer
View Study & Checklist ➔Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Borderline Ovarian Mucinous Tumor
View Study & Checklist ➔Neratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Gastroesophageal Cancer
📍 Moffitt Cancer Center — Tampa, Florida
GastroEsophageal Cancer
View Study & Checklist ➔Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03)
📍 Research Site — Baltimore, Maryland
Gastric Cancer
View Study & Checklist ➔A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
📍 UC San Diego Moores Cancer Center — La Jolla, California
Lymphoma
View Study & Checklist ➔Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Stage II Colorectal Cancer AJCC v8
View Study & Checklist ➔Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver
📍 Memorial Sloan Kettering Cancer Center — Basking Ridge, New Jersey
Colorectal Cancer
View Study & Checklist ➔Nivolumab, Ipilimumab and Chemoradiation in Treating Patients With Resectable Gastric Cancer
📍 M D Anderson Cancer Center — Houston, Texas
Clinical Stage 0 Gastric Cancer AJCC v8
View Study & Checklist ➔A Study of Nivolumab, Nivolumab Plus Ipilimumab, or Investigator's Choice Chemotherapy for the Treatment of Participants With Deficient Mismatch Repair (dMMR)/Microsatellite Instability High (MSI-H) Metastatic Colorectal Cancer (mCRC)
📍 Local Institution - 0059 — Los Angeles, California
Metastatic Colorectal Cancer
View Study & Checklist ➔ELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer
📍 BRCR Medical Center Inc. — Plantation, Florida
HER2-positive Breast Cancer
View Study & Checklist ➔Aldesleukin With Nivolumab and Standard Chemotherapy for Treatment of Gastric Cancer With Peritoneal Metastasis
📍 Mayo Clinic in Rochester — Rochester, Minnesota
Clinical Stage IV Gastric Cancer AJCC v8
View Study & Checklist ➔Testing the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After Long-Course Radiation Therapy for Advanced-Stage Rectal Cancers to Improve the Rate of Complete Response and Long-Term Rates of Organ Preservation
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Locally Advanced Rectal Carcinoma
View Study & Checklist ➔Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer
📍 Cancer Care Center at John Muir Health - Concord Campus — Concord, California
Colorectal Cancer
View Study & Checklist ➔Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
Pancreatic Cancer
View Study & Checklist ➔A Study of Subcutaneously Injected Epcoritamab Plus Oral Lenalidomide Tablets Compared to Intravenously (IV) Infused Rituximab Plus IV Infused Gemcitabine and IV Infused Oxaliplatin in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
📍 City of Hope National Medical Center /ID# 273338 — Duarte, California
Diffuse Large B-Cell Lymphoma
View Study & Checklist ➔A Phase III Study Evaluating Glofitamab in Combination With Gemcitabine + Oxaliplatin vs Rituximab in Combination With Gemcitabine + Oxaliplatin in Participants With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
📍 University of Alabama at Birmingham — Birmingham, Alabama
Diffuse Large B-cell Lymphoma
View Study & Checklist ➔Intraperitoneal Oxaliplatin and Fluorouracil for the Treatment of Patients With Peritoneal Metastases From Colorectal Cancer
📍 Ohio State University Comprehensive Cancer Center — Columbus, Ohio
Metastatic Colorectal Carcinoma
View Study & Checklist ➔Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Colon Adenocarcinoma
View Study & Checklist ➔A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer
📍 Mayo Clinic Hospital — Phoenix, Arizona
Neoplasms
View Study & Checklist ➔A Study of AK112 With or Without AK117 in Metastatic Colorectal Cancer
📍 Summit Therapeutics Research Site — Los Angeles, California
Metastatic Colorectal Cancer
View Study & Checklist ➔A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN) 18.2-positive, HER2-negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (GLOW).
📍 Pacific Cancer Care — Monterey, California
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer
View Study & Checklist ➔Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors
📍 University of California Los Angeles UCLA - Cancer Care - Santa Monica — Santa Monica, California
Locally Advanced Unresectable or Metastatic Solid Tumors Including Esophageal Cancer
View Study & Checklist ➔Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal Cancer
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Colorectal Adenocarcinoma
View Study & Checklist ➔A Study to Evaluate the Adverse Events, Efficacy, and Optimal Dose of Intravenous (IV) ABBV-400 in Combination With IV Fluorouracil, Leucovorin, and Budigalimab in Adult Participants With Locally Advanced Unresectable or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
📍 City of Hope National Medical Center /ID# 268690 — Duarte, California
Locally Advanced Unresectable or Metastatic Gastric Adenocarcinoma
View Study & Checklist ➔A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers
📍 Hospital de Gastroenterología Dr Bonorino Udaondo — Buenos Aires,
Gastric Neoplasms
View Study & Checklist ➔Nivolumab and Ipilimumab in Combination With Immunogenic Chemotherapy for Patients With Advanced NSCLC
📍 UC San Diego Moores Cancer Center — La Jolla, California
Advanced NSCLC
View Study & Checklist ➔Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer
📍 Mayo Clinic Hospital in Arizona — Phoenix, Arizona
Clinical Stage I Esophageal Adenocarcinoma AJCC v8
View Study & Checklist ➔A Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus Chemotherapy, for People With an Upper Gastrointestinal Tract Cancer That Cannot be Removed With Surgery That Has Spread to Other Parts of the Body
📍 Research Site — Los Angeles, California
Advanced Upper Gastrointestinal Tract Adenocarcinoma
View Study & Checklist ➔Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic Cancer
📍 Mayo Clinic in Rochester — Rochester, Minnesota
Locally Advanced Pancreatic Adenocarcinoma
View Study & Checklist ➔Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers
📍 Research Site — Phoenix, Arizona
Advanced Cancer
View Study & Checklist ➔TAS-102 and Oxaliplatin for the Treatment of Refractory Stage IV Colon Cancer
📍 Trinitas Hospital and Comprehensive Cancer Center — Elizabeth, New Jersey
Metastatic Colorectal Carcinoma
View Study & Checklist ➔Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery
📍 Children's Hospital of Alabama — Birmingham, Alabama
Childhood Hepatocellular Carcinoma
View Study & Checklist ➔A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer.
📍 University of Arizona — Phoenix, Arizona
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer
View Study & Checklist ➔Sonoporation and Chemotherapy for the Treatment of Pancreatic Cancer
📍 Sidney Kimmel Cancer Center at Thomas Jefferson University — Philadelphia, Pennsylvania
Locally Advanced Pancreatic Ductal Adenocarcinoma
View Study & Checklist ➔Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers
📍 Mayo Clinic Hospital — Phoenix, Arizona
Colorectal Carcinoma
View Study & Checklist ➔A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.
📍 Highlands Oncology Group, PA — Fayetteville, Arkansas
Carcinoma, Pancreatic Ductal
View Study & Checklist ➔Testing the Addition of Atezolizumab to Combination Chemotherapy or Atezolizumab Alone for Metastatic Colon or Rectal Cancer, the COMMIT Study
📍 Kingman Regional Medical Center — Kingman, Arizona
Metastatic Colorectal Adenocarcinoma
View Study & Checklist ➔Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial)
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Advanced Biliary Tract Carcinoma
View Study & Checklist ➔FOLFOX and Bevacizumab in Combination With Botensilimab and Balstilimab (3B-FOLFOX) for the Treatment of Microsatellite Stable (MSS) Metastatic Colorectal Cancer
📍 City of Hope Medical Center — Duarte, California
Metastatic Colon Adenocarcinoma
View Study & Checklist ➔Testing the Addition of an Immunotherapy Agent, Atezolizumab, When Given With the Usual Chemo-Immunotherapy Drug Combination (Rituximab Plus Gemcitabine and Oxaliplatin) for Relapsed/Refractory (That Has Come Back or Not Responded to Treatment) Transformed Diffuse Large B-Cell Lymphoma
📍 City of Hope Comprehensive Cancer Center — Duarte, California
Recurrent Diffuse Large B-Cell Lymphoma
View Study & Checklist ➔A Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors
📍 Local Institution - 0003 — Tucson, Arizona
Advanced Solid Tumors
View Study & Checklist ➔Study to Evaluate Loncastuximab Tesirine With Rituximab Versus Immunochemotherapy in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
📍 University of California San Diego Moores Cancer Center — La Jolla, California
Relapsed Diffuse Large B-Cell Lymphoma
View Study & Checklist ➔Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
📍 Anchorage Associates in Radiation Medicine — Anchorage, Alaska
Colon Adenocarcinoma
View Study & Checklist ➔A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors
📍 University of Alabama at Birmingham — Birmingham, Alabama
Pancreatic Ductal Adenocarcinoma
View Study & Checklist ➔Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophageal Junction (GEJ) Cancer
📍 Kaiser Permanente Dublin — Dublin, California
Clinical Stage I Gastric Cancer AJCC v8
View Study & Checklist ➔Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body
📍 Anchorage Associates in Radiation Medicine — Anchorage, Alaska
Clinical Stage IV Esophageal Adenocarcinoma AJCC v8
View Study & Checklist ➔A Study of Zolbetuximab (IMAB362) in Adults With Gastric Cancer
📍 The Angeles Clinic and Research Institute — Los Angeles, California
Pharmacokinetics of Zolbetuximab
View Study & Checklist ➔Botensilimab and Balstilimab Optimization in Colorectal Cancer
📍 Duke University — Durham, North Carolina
Colorectal Cancer
View Study & Checklist ➔EGF-Depleting Therapy CIMAvax-EGF in Combination With Standard Therapy for RAS- and BRAF Wild-Type Metastatic Colorectal Cancer
📍 Roswell Park Comprehensive Cancer Center — Buffalo, New York
Colo-rectal Cancer
View Study & Checklist ➔A Safety and Efficacy Study of Treatment Combinations With and Without Chemotherapy in Adult Participants With Advanced Upper Gastrointestinal Tract Malignancies
📍 Research Site — Phoenix, Arizona
Gastrointestinal Tract Malignancies
View Study & Checklist ➔Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Pancreatic Adenosquamous Carcinoma
View Study & Checklist ➔DCE-MRI for Neoadjuvant Treatment Assessment in Patients With Borderline Resectable Pancreatic Cancer
📍 Ohio State University Comprehensive Cancer Center — Columbus, Ohio
Borderline Resectable Pancreatic Ductal Adenocarcinoma
View Study & Checklist ➔Neoadjuvant Intra-tumoral RP2 and FLOT in Gastroesophageal Adenocarcinoma
📍 Abramson Cancer Center at the University of Pennsylvania — Philadelphia, Pennsylvania
Gastric Adenocarcinoma
View Study & Checklist ➔SMAD4 Tailored Neoadjuvant Therapy for the Treatment of Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma, SMART-PANC Trial
📍 Northwestern University — Chicago, Illinois
Borderline Resectable Pancreatic Ductal Adenocarcinoma
View Study & Checklist ➔Combining DCSZ11 With Radiation and Chemotherapy as Neoadjuvant Treatment for pMMR Locally Advanced Rectal Cancer
📍 Johns Hopkins SKCCC — Baltimore, Maryland
Rectal Cancer
View Study & Checklist ➔Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)
📍 UPMC Hillman Cancer Center ( Site 1904) — Pittsburgh, Pennsylvania
Esophageal Squamous Cell Carcinoma
View Study & Checklist ➔A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)
📍 Moffitt Cancer Center ( Site 0261) — Tampa, Florida
Advanced Solid Tumors
View Study & Checklist ➔Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
📍 The University of Arizona Cancer Center-North Campus — Tucson, Arizona
Pancreatic Cancer
View Study & Checklist ➔Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Metastatic Colorectal Carcinoma
View Study & Checklist ➔Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Advanced Malignant Solid Neoplasm
View Study & Checklist ➔Oxaliplatin and Liposomal Irinotecan (Plus Trastuzumab for HER2-positive Disease) in Advanced Esophageal and Gastric Adenocarcinoma
📍 University of Wisconsin Carbone Cancer Center — Madison, Wisconsin
Esophageal Adenocarcinoma
View Study & Checklist ➔A Study to Evaluate Efficacy and Safety of Tislelizumab Plus Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma in Racial and Ethnic Minority Patients in the United States
📍 Helios Clinical Research — Cerritos, California
Advanced Unresectable Gastric Adenocarcinoma
View Study & Checklist ➔Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
📍 Cancer Center at Saint Joseph's — Phoenix, Arizona
Rectal Cancer
View Study & Checklist ➔Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia
📍 Mayo Clinic Health Systems-Mankato — Mankato, Minnesota
Clonal Cytopenia of Undetermined Significance
View Study & Checklist ➔AACR Adaptive Biomarker-Driven Organ Preservation Trial in Gastroesophageal Adenocarcinomas
📍 University of California, Los Angeles — Los Angeles, California
Gastroesophageal Adenocarcinoma
View Study & Checklist ➔NALIRIFOX Before Surgery for the Treatment of Borderline Resectable Pancreatic Ductal Adenocarcinoma, Nectar Trial
📍 Roswell Park Cancer Institute — Buffalo, New York
Borderline Resectable Pancreatic Ductal Adenocarcinoma
View Study & Checklist ➔PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
📍 City of Hope Medical Center — Duarte, California
Clinical Stage IV Gastric Cancer AJCC v8
View Study & Checklist ➔Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
📍 Research Site — Mobile, Alabama
Gastric Cancer
View Study & Checklist ➔Pan Tumor Rollover Study
📍 Local Institution - 0220 — Huntsville, Alabama
Cancer
View Study & Checklist ➔A Study of ASP1002 in Adults for Treatment of Solid Tumors
📍 Yale University Cancer Center — New Haven, Connecticut
Advanced Solid Tumors
View Study & Checklist ➔Chemoradiotherapy Followed by Planned Surgery or by Surveillance and Surgery Only When Needed for Oesophageal Cancer
📍 McGill University Health Centre — Montreal, Quebec
Esophageal Squamous Cell Carcinoma
View Study & Checklist ➔Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer
📍 Johns Hopkins Sidney Kimmel Comprehensive Cancer Center — Baltimore, Maryland
Colorectal Cancer
View Study & Checklist ➔A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
📍 City of Hope National Medical Center /ID# 270255 — Duarte, California
Metastatic Colorectal Cancer
View Study & Checklist ➔Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer
📍 UF Health Cancer Institute - Gainesville — Gainesville, Florida
Metastatic Colorectal Adenocarcinoma
View Study & Checklist ➔Low Dose Epcoritamab Plus GemOx in R/R DLBCL
📍 Hospital Universitario "Dr. José Eleuterio González" — Monterrey, Nuevo León
Relapsed/Refractory Diffuse Large B Cell Lymphoma
View Study & Checklist ➔A Study of ASP3082 in Adults With Advanced Solid Tumors
📍 City of Hope National Medical Center — Duarte, California
Solid Tumor
View Study & Checklist ➔Phase II Open-label Trial of Neoadjuvant Immunochemotherapy for Resectable Non-metastatic Colon cancER: NICER
📍 Baylor College of Medicine — Houston, Texas
Stage I Colon Cancer
View Study & Checklist ➔A Study of CDX-1140, a CD40 Agonist, in Combination With Capecitabine and Oxaliplatin (CAPOX) and Keytruda in Subjects With Biliary Tract Carcinoma (BTC)
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
Biliary Cancer
View Study & Checklist ➔Epcoritamab, Rituximab, Gemcitabine and Oxaliplatin (R-GemOx) as Salvage Therapy Before Autologous Stem Cell Transplant for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
📍 City of Hope Medical Center — Duarte, California
Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
View Study & Checklist ➔A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer
📍 Massachusetts General Hospital (Data Collection Only) — Boston, Massachusetts
Esophageal Cancer
View Study & Checklist ➔A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
📍 Palo Verde Hematology Oncology — Glendale, Arizona
Colorectal Neoplasms
View Study & Checklist ➔A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
📍 University of California Irvine Medical Center — Orange, California
Gastric Adenocarcinoma
View Study & Checklist ➔mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Advanced Esophageal Adenocarcinoma
View Study & Checklist ➔A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
Colorectal Neoplasms
View Study & Checklist ➔A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric Cancer
📍 Pan American Center for Oncology Trials — Dorado,
Gastric Adenocarcinoma
View Study & Checklist ➔Study of NALIRIFOX in Advanced Unresectable Small Bowel Tumors
📍 Moffitt Cancer Center — Tampa, Florida
Small Bowel Adenocarcinoma
View Study & Checklist ➔Propranolol in Combination With Pembrolizumab and Standard Chemotherapy for the Treatment of Unresectable Locally Advanced or Metastatic Esophageal or Gastroesophageal Junction Adenocarcinoma
📍 Roswell Park Cancer Institute — Buffalo, New York
Clinical Stage II Esophageal Adenocarcinoma AJCC v8
View Study & Checklist ➔Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer
📍 UCLA / Jonsson Comprehensive Cancer Center — Los Angeles, California
Locally Advanced Rectal Carcinoma
View Study & Checklist ➔SMART TNT for the Conservative Management of Locally Advanced Rectal Cancer
📍 University of Miami — Miami, Florida
Locally Advanced Rectal Cancer
View Study & Checklist ➔A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer
📍 Mayo Clinic Arizona — Phoenix, Arizona
Colorectal Cancer
View Study & Checklist ➔Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)
📍 I-Mab Site 1016 — Goodyear, Arizona
Solid Tumor
View Study & Checklist ➔A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
📍 Mayo Clinic Hospital — Phoenix, Arizona
Colorectal Neoplasms
View Study & Checklist ➔Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
📍 Fairbanks Memorial Hospital — Fairbanks, Alaska
Ampulla of Vater Carcinoma
View Study & Checklist ➔ctDNA-Directed Post-Hepatectomy Chemotherapy for Patients With Resectable Colorectal Liver Metastases
📍 M D Anderson Cancer Center — Houston, Texas
Liver Metastases
View Study & Checklist ➔MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
📍 City of Hope — Duarte, California
Pancreatic Ductal Adenocarcinoma
View Study & Checklist ➔A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors
📍 START Los Angeles, LLC — Los Angeles, California
Advanced Solid Tumors
View Study & Checklist ➔Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer
📍 University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center — Cleveland, Ohio
Biliary Tract Cancer
View Study & Checklist ➔